Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery disease (CAD), allowing for reclassification to a lower disease category in 54% of patients, according to
AbbVie announced Tuesday that CEO Richard Gonzalez, who has managed the company’s ascent since it was spun off from the device maker Abbott Laboratories in
Annual breast cancer screening beginning at age 40 and continuing to at least age 79 results in the highest reduction in mortality with minimal risks,
Hyperbaric oxygen therapy, giving patients 100 percent oxygen at a pressure corresponding to 10-20 meters below sea level, has been around for almost 100 years.
Researchers unveiled a novel therapy for diabetic wound healing. This research highlights the use of exosomal miR-4645-5p from hypoxic bone marrow mesenchymal stem cells (BMSCs)
Vancouver, Canada, Feb. 20, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of
Denver is set to host the illustrious Psychedelic Science Conference in 2025, organized by the esteemed Multidisciplinary Association for Psychedelic Studies (MAPS). This grand event
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. The need-to-know this morning
Good morning, everyone, and welcome to another working week, which is getting off to a late start on this side of the pond thanks to
Nathaniel Arana, CEO at NGA Healthcare As a society, we should all be concerned about the increasing rate at which private equity firms are acquiring